William S. Krimsky - Galvanize Therapeutics®
Skip to the content
Headshot of William S. Krimsky, Chief Medical Officer

William S. Krimsky, MD, FCCP, DAABIP

Chief Medical Officer

William Krimsky is Chief Medical Officer of Galvanize Therapeutics. Bill has been a pioneer in the Interventional Pulmonology space for more than 20 years, carving an innovative pathway for the treatment of lung diseases. In 2015, he and Jonathan Waldstreicher co-founded Galvanize Therapeutics and co-invented the Aliya® and RheOx® technologies, continuing his focus on therapeutic intervention in the pulmonary and oncology fields. Bill earned his medical degree at the University of Pittsburgh School of Medicine and completed an internship at Mercy Hospital and a residency at Johns Hopkins University/Sinai Hospital. Following that, he was a fellow in pulmonary and critical care medicine at Dartmouth-Hitchcock Medical Center and a visiting fellow in Interventional Pulmonology at the Hospital of the University of Pennsylvania. He is the author of multiple publications.

Important Notice:

Galvanize Therapeutics® is a medical device manufacturer, not a healthcare provider. The information submitted through this form will be used solely to connect you with a physician in your area who uses the Aliya® PEF System. Please do not submit protected health information (PHI) — including diagnosis, treatment history, or medical records — through this form.

The Aliya® PEF System (K212871, K233884, and K253826) is 510(k) cleared in the United States for the surgical ablation of soft tissue. Galvanize Therapeutics® does not promote the off-label use of its products and nothing herein is intended to promote an off-label use of the Aliya PEF System. The Aliya PEF System is a tool for the surgical ablation of soft tissue it is not intended to treat, cure, prevent, nor mitigate any specific disease or condition.

For questions about coverage or eligibility for this procedure, please consult your physician and insurance provider.

I Understand